References
- Misra R, Sahoo SK. Coformulation of doxorubicin and curcumin in poly (D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm. 2011;8:852–866.
- Huang W, Wu Q-D, Zhang M, et al. Novel Hsp90 inhibitor FW-04-806 displays potent antitumour effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib. Cancer Lett. 2015;356:862–871.
- Jiang H, Xu L, Liu D, et al. Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis. Bone Marrow Transpl. 2014;49:1146–1154.
- Duan J, Mansour HM, Zhang Y, et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly (butyl cyanoacrylate) nanoparticles. Int J Pharm. 2012;426:193–201.
- Pramanik D, Campbell NR, Das S, et al. A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget. 2012;3:640–650.
- Wang B-L, Shen Y-M, Zhang Q-W, et al. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomed. 2013;8:3521.
- Barui S, Saha S, Mondal G, et al. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumour vasculature. Biomaterials. 2014;35:1643–1656.
- Ueno Y, Futagawa H, Takagi Y, et al. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release. 2005;103:93–98.
- Sharma S, Verma A, Teja BV, et al. An insight into functionalized calcium based inorganic nanomaterials in biomedicine: trends and transitions. Colloids Surf B Biointerfaces. 2015;133:120–139.
- Zhao D, Wang C-Q, Zhuo R-X, Cheng S-X. Modification of nanostructured calcium carbonate for efficient gene delivery. Colloids Surf B Biointerfaces. 2014;118:111–116.
- Gong M-Q, Wu J-L, Chen B, et al. Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy. Langmuir. 2015;31:5115–5122.
- Min KH, Min HS, Lee HJ, et al. pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers. ACS Nano. 2015;9:134–145.
- Kitaeva M, Melik-Nubarov N, Menger F, Yaroslavov A. Doxorubicin-poly(acrylic acid) complexes: interaction with liposomes. Langmuir. 2004;20:6575–6579.
- Abdalkader R, Kawakami S, Unga J, et al. Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumour model. Acta Biomater. 2015;19:112–118.
- Sadzuka Y, Nagamine M, Toyooka T, et al. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm. 2012;432:42–49.
- Fang JH, Lai YH, Chiu TL, et al. Magnetic core–shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas. Adv Healthc Mater. 2014;3:1250–1260.
- Li H, Li M, Chen C, et al. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier. Int J Pharm. 2015;495:572–578.
- Li J, Chen Y-C, Tseng Y-C, et al. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J Control Release. 2010;142:416–421.
- Li J, Yang Y, Huang L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumour. J Control Release. 2012;158:108–114.
- Kim SK, Foote MB, Huang L. Targeted delivery of EV peptide to tumour cell cytoplasm using lipid coated calcium carbonate nanoparticles. Cancer Lett. 2013;334:311–318.
- Hu Y, Haynes MT, Wang Y, et al. A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo. ACS Nano. 2013;7:5376–5384.